It is therefore consensus in the scientific community that combination therapies are required to target the different components of the disease process and thereby reverse diabetic hyperglycaemia through suppression of the autoimmune-mediated beta cell destructive process and the subsequent regeneration of the insulin-producing cells [6–9]. Here, INS is linked to Hyperglycemia.